Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Osteoarthritis
Interventions
DRUG

Naproxen

nonsteroidal anti-inflammatory drug

DIETARY_SUPPLEMENT

flavocoxid 250 mg

flavonoid mixture

DIETARY_SUPPLEMENT

flavocoxid 500 mg

flavonoid mixture

Trial Locations (1)

85251

Primus Pharmaceuticals, Inc, Scottsdale

Sponsors
All Listed Sponsors
lead

Primus Pharmaceuticals

INDUSTRY